TMC435 150 Pill - white capsule/oblong
Generic Name: simeprevir
Pill with imprint TMC435 150 is White, Capsule/Oblong and has been identified as Olysio 150 mg. It is supplied by Janssen Therapeutics.
Olysio is used in the treatment of Hepatitis C and belongs to the drug class protease inhibitors. Not for use in pregnancy. Olysio 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TMC435 150



Olysio
- Generic Name
- simeprevir
- Imprint
- TMC435 150
- Strength
- 150 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Therapeutics
- National Drug Code (NDC)
- 09676-0225
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Mavyret
Mavyret is used to treat adults and children 3 years of age and older with acute or chronic ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
More about Olysio (simeprevir)
- Check interactions
- Compare alternatives
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: protease inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.